Abstract
Objective:
Whether hormone supplementation is necessary for infants with transient hypothyroxinemia of prematurity (THOP) remains controversial, and further analysis of the hypothalamus–pituitary–thyroid axis of infants with THOP is necessary.
Study Design:
Thyrotropin-releasing hormone (TRH) stimulation tests were performed at 2 weeks of age in 50 infants with a gestational age of 30 weeks or less, and the data were analyzed retrospectively.
Result:
Subjects were divided into three groups; group A consisted of euthyroid infants, group B consisted of infants with THOP and group C consisted of hypothyroid infants. The basal and peak thyroid-stimulating hormone level of group C in response to TRH stimulation tests was significantly higher than the others, but no differences were observed between groups A and B.
Conclusion:
The response of infants with THOP to the TRH stimulation test was not different from that of euthyroid infants, which suggested that their hypothalamic–pituitary–thyroid axis was appropriately regulated in infants with THOP.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Reuss ML, Leviton A, Paneth N, Susser M . Thyroxine values from newborn screening of 919 infants born before 29 weeks’ gestation. Am J Public Health 1997; 87 (10): 1693–1697.
Sureka Bollepalli SRR . Disorders of the thyroid gland. In: Christine A, Gleason SUD (eds) Avery’s Disease of the Newborn. 9th edn, Elsevier: Philadelphia, PA, USA, 2012, pp 1307–1319.
Rapaport R, Rose SR, Freemark M . Hypothyroxinemia in the preterm infant: the benefits and risks of thyroxine treatment. J Pediatr 2001; 139 (2): 182–188.
van Wassenaer AG, Kok JH, de Vijlder JJ, Briet JM, Smit BJ, Tamminga P et al. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks’ gestation. N Engl J Med 1997; 336 (1): 21–26.
Osborn DA, Hunt RW . Postnatal thyroid hormones for preterm infants with transient hypothyroxinaemia. Cochrane Database Syst Rev 2007; (1): CD005945.
Briet JM, van Wassenaer AG, Dekker FW, de Vijlder JJ, van Baar A, Kok JH . Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age. Pediatrics 2001; 107 (4): 712–718.
La Gamma EF, van Wassenaer AG, Ares S, Golombek SG, Kok JH, Quero J et al. Phase 1 trial of 4 thyroid hormone regimens for transient hypothyroxinemia in neonates of <28 weeks’ gestation. Pediatrics 2009; 124 (2): e258–e268.
van Wassenaer-Leemhuis A, Ares S, Golombek S, Kok J, Paneth N, Kase J et al. Thyroid hormone supplementation in preterm infants born before 28 weeks gestational age and neurodevelopmental outcome at age 36 months. Thyroid 2014; 24 (7): 1162–1169.
Niwa F, Kawai M, Kanazawa H, Iwanaga K, Matsukura T, Hasegawa T et al. Hyperthyrotropinemia at 2 weeks of age indicates thyroid dysfunction and predicts the occurrence of delayed elevation of thyrotropin in very low birth weight infants. Clin Endocrinol (Oxf) 2012; 77 (2): 255–261.
Okada J, Iwata S, Hirose A, Kanda H, Yoshino M, Maeno Y et al. Levothyroxine replacement therapy and refractory hypotension out of transitional period in preterm infants. Clin Endocrinol (Oxf) 2011; 74 (3): 354–364.
Kawai M, Kusuda S, Cho K, Horikawa R, Takizawa F, Ono M et al. Nationwide surveillance of circulatory collapse associated with levothyroxine administration in very-low-birthweight infants in Japan. Pediatr Int 2012; 54 (2): 177–181.
Takizawa F, Kashimada K, Enomoto K, Miyai K, Ono M, Asada G et al. Two preterm infants with late onset circulatory collapse induced by levothyroxine sodium. Pediatr Int 2010; 52 (3): e154–e157.
Yagasaki H, Kobayashi K, Nemoto A, Naito A, Sugita K, Ohyama K . Late-onset circulatory dysfunction after thyroid hormone treatment in an extremely low birth weight infant. J Pediatr Endocrinol Metab 2010; 23 (1–2): 153–158.
Rapaport R, Sills I, Patel U, Oppenheimer E, Skuza K, Horlick M et al. Thyrotropin-releasing hormone stimulation tests in infants. J Clin Endocrinol Metab 1993; 77 (4): 889–894.
de Zegher F, Pernasetti F, Vanhole C, Devlieger H, Van den Berghe G, Martial JA . The prenatal role of thyroid hormone evidenced by fetomaternal Pit-1 deficiency. J Clin Endocrinol Metab 1995; 80 (11): 3127–3130.
Vulsma T, Gons MH, de Vijlder JJ . Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med 1989; 321 (1): 13–16.
Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999; 341 (8): 549–555.
van Wassenaer AG, Kok JH, Dekker FW, de Vijlder JJ . Thyroid function in very preterm infants: influences of gestational age and disease. Pediatr Res 1997; 42 (5): 604–609.
Den Ouden AL, Kok JH, Verkerk PH, Brand R, Verloove-Vanhorick SP . The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants. Pediatr Res 1996; 39 (1): 142–145.
Ares S, Quero J, Diez J, Morreale de Escobar G . Neurodevelopment of preterm infants born at 28 to 36 weeks of gestational age: the role of hypothyroxinemia and long-term outcome at 4 years. J Pediatr Endocrinol Metab 2011; 24 (11-12): 897–902.
Leviton A, Paneth N, Reuss ML, Susser M, Allred EN, Dammann O et al. Hypothyroxinemia of prematurity and the risk of cerebral white matter damage. J Pediatr 1999; 134 (6): 706–711.
Lucas A, Morley R, Fewtrell MS . Low triiodothyronine concentration in preterm infants and subsequent intelligence quotient (IQ) at 8 year follow up. BMJ 1996; 312 (7039): 1132–1133; discussion 1133-1134.
Meijer WJ, Verloove-Vanhorick SP, Brand R, van den Brande JL . Transient hypothyroxinaemia associated with developmental delay in very preterm infants. Arch Dis Child 1992; 67 (7): 944–947.
Hadeed AJ, Asay LD, Klein AH, Fisher DA . Significance of transient postnatal hypothyroxinemia in premature infants with and without respiratory distress syndrome. Pediatrics 1981; 68 (4): 494–498.
Cuestas RA, Engel RR . Thyroid function in preterm infants with respiratory distress syndrome. J Pediatr 1979; 94 (4): 643–646.
Polk DH, Reviczky A, Lam RW, Fisher DA . Thyrotropin-releasing hormone in ovine fetus: ontogeny and effect of thyroid hormone. Am J Physiol 1991; 260 (1 Pt 1): E53–E58.
Koivusalo F . Evidence of thyrotropin-releasing hormone activity in autopsy pancreata from newborns. J Clin Endocrinol Metab 1981; 53 (4): 734–736.
Kaptein EM, Beale E, Chan LS . Thyroid hormone therapy for obesity and nonthyroidal illnesses: a systematic review. J Clin Endocrinol Metab 2009; 94 (10): 3663–3675.
Biondi B, Cooper DS . The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008; 29 (1): 76–131.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Yamamoto, A., Kawai, M., Iwanaga, K. et al. Response to thyrotropin-releasing hormone stimulation tests in preterm infants with transient hypothyroxinemia of prematurity. J Perinatol 35, 725–728 (2015). https://doi.org/10.1038/jp.2015.67
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2015.67